BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 10618689)

  • 21. Phase II trial of mitoxantrone in advanced gastric cancer.
    Goldenberg A; Kelsen D; Benedetto P
    Oncology; 1988; 45(4):273-5. PubMed ID: 3290754
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Phase I study of oral spirogermanium.
    Harvey J; McFadden M; Smith FP; Joubert L; Schein PS
    Invest New Drugs; 1990 Feb; 8(1):53-6. PubMed ID: 2345069
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Phase I-II study of 5-fluorouracil, leucovorin, doxorubicin, methotrexate, and long-term oral etoposide (FLAME) in unresectable or metastatic gastric cancer.
    Bjarnason GA; Cripps C; Goel R; Fine S; Oza AM; Skillings JR; Kerr I; Germond CJ; Moore MJ; Maroun JA; Franssen E; Dulude H
    Am J Clin Oncol; 1998 Dec; 21(6):537-42. PubMed ID: 9856651
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nivolumab in patients with advanced gastric or gastro-oesophageal junction cancer refractory to, or intolerant of, at least two previous chemotherapy regimens (ONO-4538-12, ATTRACTION-2): a randomised, double-blind, placebo-controlled, phase 3 trial.
    Kang YK; Boku N; Satoh T; Ryu MH; Chao Y; Kato K; Chung HC; Chen JS; Muro K; Kang WK; Yeh KH; Yoshikawa T; Oh SC; Bai LY; Tamura T; Lee KW; Hamamoto Y; Kim JG; Chin K; Oh DY; Minashi K; Cho JY; Tsuda M; Chen LT
    Lancet; 2017 Dec; 390(10111):2461-2471. PubMed ID: 28993052
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Phase II trial of etoposide, doxorubicin, and cisplatin combination in advanced measurable gastric cancer. An Eastern Cooperative Oncology Group study.
    Clark JL; Küçük O; Neuberg DS; Benson AB; Taylor SG; Pandya KJ; Mansour EG; Douglass HO; Haller DG
    Am J Clin Oncol; 1995 Aug; 18(4):318-24. PubMed ID: 7625373
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A phase II study of pegylated-camptothecin (pegamotecan) in the treatment of locally advanced and metastatic gastric and gastro-oesophageal junction adenocarcinoma.
    Scott LC; Yao JC; Benson AB; Thomas AL; Falk S; Mena RR; Picus J; Wright J; Mulcahy MF; Ajani JA; Evans TR
    Cancer Chemother Pharmacol; 2009 Jan; 63(2):363-70. PubMed ID: 18398613
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Phase II trial of spirogermanium in breast adenocarcinoma: a Cancer and Leukemia Group B Study.
    Budman DR; Ginsberg S; Perry M; Weinberg V; Schein P; Hanson J; Coleman M; Wood W
    Cancer Treat Rep; 1982 Aug; 66(8):1667-8. PubMed ID: 7105058
    [No Abstract]   [Full Text] [Related]  

  • 28. Phase II study of Taxol in patients with advanced gastric carcinoma.
    Ajani JA; Fairweather J; Dumas P; Patt YZ; Pazdur R; Mansfield PF
    Cancer J Sci Am; 1998; 4(4):269-74. PubMed ID: 9689986
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A phase II study of etoposide, doxorubicin, and carboplatin in the treatment of advanced gastric cancer.
    Wang X; Pang L; Feng J
    Am J Clin Oncol; 2002 Feb; 25(1):71-5. PubMed ID: 11823701
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Final results of a randomized phase III trial of sequential high-dose methotrexate, fluorouracil, and doxorubicin versus etoposide, leucovorin, and fluorouracil versus infusional fluorouracil and cisplatin in advanced gastric cancer: A trial of the European Organization for Research and Treatment of Cancer Gastrointestinal Tract Cancer Cooperative Group.
    Vanhoefer U; Rougier P; Wilke H; Ducreux MP; Lacave AJ; Van Cutsem E; Planker M; Santos JG; Piedbois P; Paillot B; Bodenstein H; Schmoll HJ; Bleiberg H; Nordlinger B; Couvreur ML; Baron B; Wils JA
    J Clin Oncol; 2000 Jul; 18(14):2648-57. PubMed ID: 10894863
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neoadjuvant chemotherapy with P-ELF (cisplatin, etoposide, leucovorin, 5-fluorouracil) followed by radical resection in patients with initially unresectable gastric adenocarcinoma: a phase II study.
    Gallardo-Rincón D; Oñate-Ocaña LF; Calderillo-Ruiz G
    Ann Surg Oncol; 2000; 7(1):45-50. PubMed ID: 10674448
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A phase II study of spirogermanium in patients with advanced malignant lymphoma.
    Sessa C; ten Bokkel Huinik W; Clavel M; Lev LM; Joss RA; Renard J; Cavalli F
    Invest New Drugs; 1989 Jul; 7(2-3):219-22. PubMed ID: 2793376
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Oxaliplatin combined with ELF regimen in the treatment of patients with advanced gastric cancer].
    Lou F; Zhu YH; Pan HM
    Zhonghua Zhong Liu Za Zhi; 2009 Jan; 31(1):75-8. PubMed ID: 19538878
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Randomized Multicenter Phase II Study of Modified Docetaxel, Cisplatin, and Fluorouracil (DCF) Versus DCF Plus Growth Factor Support in Patients With Metastatic Gastric Adenocarcinoma: A Study of the US Gastric Cancer Consortium.
    Shah MA; Janjigian YY; Stoller R; Shibata S; Kemeny M; Krishnamurthi S; Su YB; Ocean A; Capanu M; Mehrotra B; Ritch P; Henderson C; Kelsen DP
    J Clin Oncol; 2015 Nov; 33(33):3874-9. PubMed ID: 26438119
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Randomized clinical trial comparing mitoxantrone with doxorubicin in previously treated patients with metastatic breast cancer.
    Henderson IC; Allegra JC; Woodcock T; Wolff S; Bryan S; Cartwright K; Dukart G; Henry D
    J Clin Oncol; 1989 May; 7(5):560-71. PubMed ID: 2468745
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Metastatic cancer of the prostate: phase II study of spirogermanium (NSC 192965)].
    Bui NB; Chauvergne J; Brunet R; Richaud P; Hoerni B; Lagarde C; Le Guillou M
    Bull Cancer; 1986; 73(1):65-7. PubMed ID: 3779124
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Phase II trial of etoposide, doxorubicin (Adriamycin), and cisplatin (EAP regimen) in advanced gastric cancer.
    Sparano JA; Schwartz EL; Salva KM; Pizzillo MF; Wadler S; Wiernik PH
    Am J Clin Oncol; 1990 Oct; 13(5):374-8. PubMed ID: 2220657
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Preoperative and postoperative combination chemotherapy for potentially resectable gastric carcinoma.
    Ajani JA; Mayer RJ; Ota DM; Steele GD; Evans D; Roh M; Sugarbaker DJ; Dumas P; Gray C; Vena DA
    J Natl Cancer Inst; 1993 Nov; 85(22):1839-44. PubMed ID: 8230264
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy of common salvage chemotherapy regimens in patients with refractory or relapsed acute myeloid leukemia: A retrospective cohort study.
    Xu J; Lv TT; Zhou XF; Huang Y; Liu DD; Yuan GL
    Medicine (Baltimore); 2018 Sep; 97(39):e12102. PubMed ID: 30278488
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Phase II study of oral etoposide for patients with advanced breast cancer.
    Atienza DM; Vogel CL; Trock B; Swain SM
    Cancer; 1995 Dec; 76(12):2485-90. PubMed ID: 8625074
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.